Oncology Research and Treatment

Published by: S. Karger AG  

People

  1. Chi
    Chi
  2. D'Angelo
    D'Angelo
  3. Schoenfeld
    Schoenfeld
  4. Tap
    Tap

Groups

  1. Department of Medicine (7)
  2. Sarcoma Service (7)
  3. Solid Tumor Oncology Division (7)
  4. GSK Faculty (3)
  5. Human Oncology and Pathogenesis Program (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)
  7. Hematologic Malignancies, Division of (2)
  8. Thoracic Oncology (2)
  9. Weinberg Fellows (2)
  10. Dermatology Service (1)
Search Within
  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (7)
Groups
  1. Department of Medicine (7)
  2. Sarcoma Service (7)
  3. Solid Tumor Oncology Division (7)
  4. GSK Faculty (3)
  5. Human Oncology and Pathogenesis Program (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)

More Groups

People
  1. Ping Chi (3)
  2. Adam Schoenfeld (2)
  3. Sandra D'Angelo (2)
  4. William Tap (2)
  5. Mario Lacouture (1)
Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (1)
  5. 2016 (1)
Publishers
  1. S. Karger AG (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality of life and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors: analyses from INVICTUS
    Meeting Abstract

    Bauer, S.; Heinrich, M. C.; George, S.; Zalcberg, J. R.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • ZENYTH-ESO Substudy 1 (GSK3901961), cohort 1: A first-in-human study to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with non-small cell lung cancer
    Meeting Abstract

    Wermke, M.; Ullrich, R.; Yachnin, J.; Mielke, S.; Patel, R.; Yushak, M. L.; Schoenfeld, A. J.; Desai, J.; Altan, M.; D'angelo, S. P.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma, myxoid/round cell liposarcoma and nonsmall cell lung cancer [Substudy 1 (GSK3901961) and Substudy 2 (GSK3845097)]
    Meeting Abstract

    Ullrich, R.; Wermke, M.; Yachnin, J.; Mielke, S.; Patel, R.; Yushak, M. L.; Schoenfeld, A. J.; Desai, J.; Altan, M.; D'Angelo, S. P.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    Reichardt, P.; Heinrich, M.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Clinical benefit with ripretinib as ≥ 4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study
    Meeting Abstract

    Bauer, S.; Heinrich, M.; George, S.; Zalcberg, J. R.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Long-term efficacy, tolerability, and overall survival in patients with unresectable or metastatic platelet-derived growth factor receptor A (PDGFRA) D842V-mutant gastrointestinal stromal tumors (GIST) treated with avapritinib: NAVIGATOR phase 1 trial update
    Meeting Abstract

    Bauer, S.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M. C.; Kang, Y. K.; Schöffski, P.; Cassier, P. A.; Mir, O.; Eskens, F.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (Dox) with or without olaratumab (IMC-3G3), a human anti-platelet-derived growth factor a (pdgfra) monoclonal antibody, in advanced soft tissue sarcoma (sts)
    Meeting Abstract

    Tap, W.; Jones, R. L.; Chmelowski, B.; Elias, A. A.; Adkins, D.; Van Tine, B. A.; Agulnik, M.; Cooney, M.; Livingston, M. B.; Pennock, G.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save

    • Oncology Research and Treatment – authorized name for:

    Name ISSN / ISBN Publisher
    Oncology Research and Treatment 22965270 Unknown
    Oncology Research and Treatment 2296-5270 Karger
    Oncology research and treatment 22965262 Unknown
    Oncology Research and Treatment 2296-5270 S. Karger AG
    Oncology Research and Treatment 2296-5270 S. Karger AG